| abstract |
The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof:n n n Formula In n n n n n n n Wheren n n A, R 1 to R 5 are as defined herein, and G is a pyridine, quinoline or pyrimidine group as defined herein.n n n The invention also relates to pharmaceutical compositions containing such compounds, methods for their preparation and their use for the treatment and / or prevention of diseases associated with the modulation of SST receptor subtype 5. |